Patents by Inventor Sandra Ogueta

Sandra Ogueta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pseudotyped lentiviral vectors and uses thereof
    Patent number: 7262049
    Abstract: A vector system that will produce a pseudotyped lentiviral vector that can be used to deliver a desired gene is disclosed. The vector constructs that are described include a number of modifications that enhance the safety of the vector. The vector can be used to more specifically target cells for expression of certain genes.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: August 28, 2007
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne A Marasco, Sandra Ogueta
  • Pseudotyped lentiviral vectors and uses thereof
    Patent number: 7078031
    Abstract: A vector system that will produce a pseudotyped lentiviral vector that can be used to deliver a desired gene is disclosed. The vector constructs that are described include a number of modifications that enhance the safety of the vector. The vector can be used to more specifically target cells for expression of certain genes.
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: July 18, 2006
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne A. Marasco, Sandra Ogueta
  • Pseudotyped lentiviral vectors and uses thereof
    Publication number: 20050003505
    Abstract: A vector system that will produce a pseudotyped lentiviral vector that can be used to deliver a desired gene is disclosed. The vector constructs that are described include a number of modifications that enhance the safety of the vector. The vector can be used to more specifically target cells for expression of certain genes.
    Type: Application
    Filed: May 13, 2004
    Publication date: January 6, 2005
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne Marasco, Sandra Ogueta
  • Lentiviral vector system for high quantity screening
    Patent number: 6830892
    Abstract: A method of screening for a target molecule from a group of potential target molecules is described. This method involves using a library of lentiviral vectors where the members encode the group of target molecules, then transducing a group of cells and screening the transduced cell for a desired phenotype. The cell(s) displaying the desired phenotype is selected and the target molecule is identified.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: December 14, 2004
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne A. Marasco, Sandra Ogueta
  • Pseudotyped lentiviral vectors and uses thereof
    Publication number: 20030044981
    Abstract: A vector system that will produce a pseudotyped lentiviral vector that can be used to deliver a desired gene is disclosed. The vector constructs that are described include a number of modifications that enhance the safety of the vector. The vector can be used to more specifically target cells for expression of certain genes.
    Type: Application
    Filed: September 14, 2001
    Publication date: March 6, 2003
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne A. Marasco, Sandra Ogueta
  • Lentiviral vector system for high quantity screening
    Publication number: 20020155430
    Abstract: A method of screening for a target molecule from a group of potential target molecules is described. This method involves using a library of lentiviral vectors where the members encode the group of target molecules, then transducing a group of cells and screening the transduced cell for a desired phenotype. The cell(s) displaying the desired phenotype is selected and the target molecule is identified.
    Type: Application
    Filed: September 14, 2001
    Publication date: October 24, 2002
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne A. Marsco, Sandra Ogueta